Sign in to continue:

Thursday, April 2nd, 2026

RYTHM, Inc. Amends License Agreements with Green Thumb Industries for $70 Million Annual Fee and Strengthens Long-Term Revenue 1




RYTHM, Inc. Announces Significant Amendments to License Agreements with Green Thumb Industries

RYTHM, Inc. Announces Significant Amendments to License Agreements with Green Thumb Industries

Key Highlights

  • Amendments to License Agreements: RYTHM, Inc. (Nasdaq: RYM) has announced major amendments to its existing trademark and recipe license agreements with an indirect wholly-owned subsidiary of Green Thumb Industries Inc.
  • Substantial Fixed Cash Fee: Effective April 1, 2026, Green Thumb will pay RYTHM an aggregate fixed cash fee of \$70 million. This fee is subject to an annual increase calculated as two times a Consumer Price Index-based escalator.
  • Brands Covered: The amendments cover the use of several high-profile brand intellectual properties, including RYTHM, incredibles, Beboe, Dogwalkers, Doctor Solomon’s, &Shine, and Good Green.
  • Long-Term Revenue Predictability: The company emphasizes that this arrangement establishes “predictable, long-term revenue” that is “virtually unmatched in the THC space,” providing stability and clarity for both the business and its investors.
  • Support for Nasdaq Listing: The new framework is designed to support RYTHM’s Nasdaq listing, enhancing compliance and the company’s long-term strategic position.

Details for Investors

RYTHM, Inc. is positioning itself as a leader in the U.S. THC market by leveraging its well-known portfolio of brands and securing recurring revenue streams through this landmark licensing amendment. The \$70 million fixed fee, subject to a robust annual escalator, offers a much higher degree of revenue certainty compared to typical royalty or variable-fee arrangements seen in the cannabis sector.

According to Ben Kovler, Chairman and Interim CEO, the new structure not only creates a more stable revenue base but also provides significant clarity for shareholders and investors as the regulatory landscape for THC products continues to evolve. These features can be highly attractive to institutional investors and could support the company’s stock price and market valuation.

The agreement covers an expansive portfolio of brands, including some of the most recognized and trusted names in the cannabis and hemp industries. RYTHM’s products are available in thousands of physical locations as well as online, and the company is committed to ongoing innovation to meet evolving consumer preferences.

Potential Price-Sensitive Information

  • Enhanced Revenue Visibility: The fixed, escalating cash fee provides a foundation of predictable revenue, likely to be viewed favorably by the market and analysts, potentially reducing perceived risk and supporting a higher valuation multiple.
  • Regulatory and Legal Developments: The company directly addresses the evolving federal and state regulatory environment, noting that the new agreements provide stability regardless of future legal changes.
  • Nasdaq Listing Compliance: The company highlights that the new structure supports its Nasdaq listing, which is critical for liquidity and continued access to public markets.

Forward-Looking Statements and Risks

The company advises investors that this press release contains forward-looking statements and that actual results may differ due to risks related to federal and state cannabis regulation, the ongoing relationship with Green Thumb, and general economic conditions. Investors are encouraged to review the risk factors detailed in RYTHM’s latest SEC filings.

Investor and Media Contacts


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with their financial advisor before making any investment decisions. Forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from those anticipated. Please review the company’s filings with the SEC for further risk disclosures.




View RYTHM, Inc. Historical chart here



Universal Safety Products, Inc. 2026 Annual Meeting Results & SEC Filing Highlights (NYSEAMER: UUU)

Universal Safety Products, Inc. – 2026 Annual Shareholder Me...

TScan Therapeutics, Inc. 2025 Annual Report: Business Overview, Strategy, Risks, and Pipeline Highlights

TScan Therapeutics, Inc. 2025 Annual Report — Key Investor I...

   Ad